Overview
Recognise acute kidney injury promptly, apply creatinine and urine-output staging correctly, identify immediate threats and start a cause-directed assessment before reversible injury progresses.
AKI is a clinical syndrome of abrupt loss of kidney function, not a complete diagnosis. NICE uses changes in creatinine and urine output to detect and stage it, but those markers respond on different timescales. A patient may have extensive tubular injury before creatinine has accumulated, and administered fluid may dilute the apparent rise. Conversely, a transient creatinine change can occur without established structural damage. The useful bedside task is therefore to confirm the trend, grade severity, identify complications and find the mechanism in parallel.
Initial assessment should combine ABCDE, haemodynamic and congestion examination, a reliable urine-output record, urinalysis, medication and exposure history, infection assessment and a search for obstruction. Look for the precipitating illness—vomiting, haemorrhage, sepsis, cardiac failure, surgery, urinary symptoms, contrast or a new medicine—and for evidence that the kidneys are themselves inflamed or vascularly injured. Haematuria with significant proteinuria, systemic inflammatory features, thrombocytopenia or a rapidly rising creatinine changes the urgency and differential.
Use adapted specialist pathways for children, pregnancy, kidney transplant recipients and people already receiving dialysis. In adults, align observation frequency, laboratory alerts, renal referral and medicine changes with the treating organisation’s current policies.
Aetiology
Reduced effective renal perfusion
Hypovolaemia, haemorrhage, sepsis-related vasodilatation, reduced cardiac output and severe systemic congestion can lower renal perfusion; several may coexist, and prolonged haemodynamic stress can progress to structural tubular injury.
Direct parenchymal injury
Ischaemia, sepsis, nephrotoxins, pigments, interstitial hypersensitivity, glomerular inflammation and renal vascular disease can injure tubules, interstitium, glomeruli or vessels and produce distinct urine and systemic patterns.
Urinary tract obstruction
Prostatic or bladder-outflow disease, stones, malignancy, retroperitoneal disease, clots and blocked catheters can raise upstream pressure; bilateral obstruction or obstruction of a solitary functioning kidney causes AKI.
Mixed and iatrogenic triggers
Hospital AKI is commonly multifactorial, with infection, surgery, contrast exposure, haemodynamic medicines, direct nephrotoxins and impaired drainage combining in a susceptible person with CKD, diabetes or frailty.
Pathophysiology
- 1Abrupt filtration loss
Reduced glomerular capillary pressure or filtration-surface injury lowers GFR, while creatinine accumulates only after a delay and is modified by distribution volume, production and renal secretion.
- 2Tubular dysfunction
Injured tubular cells lose polarity and transport function, obstruct the lumen and permit filtrate back-leak; impaired sodium and water handling contributes to oliguria, acidosis and electrolyte disturbance.
- 3Inflammation and microvascular injury
Endothelial dysfunction, microcirculatory shunting, leukocyte activation and interstitial oedema can sustain renal injury even after systemic blood pressure or apparent circulating volume has improved.
- 4Systemic consequences
Declining excretion and homeostasis cause potassium, acid, salt, water and uraemic-solute accumulation; severity depends on injury rate, residual kidney function, catabolic load and administered fluid or medicines.
Clinical features and red flags
A rise of at least 26 micromol/L within 48 hours or at least 50% above baseline within 7 days meets an adult AKI criterion. Search laboratory records for a credible baseline and state whether the timing is known, estimated or uncertain.
Output below 0.5 mL/kg/hour for over 6 hours is sufficient even before creatinine rises. Confirm measurement, catheter patency and body weight, and distinguish oliguria from complete anuria because anuria strongly raises obstruction or catastrophic vascular disease.
A previously reduced eGFR does not prevent an acute diagnosis. Compare current creatinine with stable historical values, examine kidney size and chronic complications, and stage the acute component from the appropriate baseline rather than labelling all impairment as chronic.
Blood and protein on urinalysis, red-cell casts if microscopy is available, hypertension, oedema, rash, pulmonary haemorrhage or systemic vasculitic features suggest glomerular or interstitial disease and warrant early nephrology discussion rather than repeated fluid challenges.
ECG change from hyperkalaemia, refractory pulmonary oedema, severe metabolic acidosis, uraemic pericarditic pain or encephalopathy, and a suspected infected obstructed system are time-critical complications whose treatment must begin while staging and cause are refined.
Investigations
- 01
Serial serum creatinine, urea and electrolytesFirst step - Why
- Confirm an acute change, stage severity and expose dangerous potassium or bicarbonate disturbance.
- Interpretation and limitations
- Plot values against dates and a reliable baseline; a rising creatinine despite resuscitation suggests continuing injury, while a falling result may lag behind clinical recovery. Urea is affected by catabolism, gastrointestinal bleeding and hydration and must not stage AKI.
- 02
Measured urine output and fluid balance - Why
- Detect oliguria early and relate renal response to intake, losses and congestion.
- Interpretation and limitations
- Use hourly output in unstable or catheterised patients and a weight-based rate where possible. Check the drainage system before calling anuria; persistent oliguria despite restored perfusion signals higher risk, but preserved output does not exclude severe AKI.
- 03
Urinalysis with urine albumin or protein quantification - Why
- Separate a bland haemodynamic or tubular picture from glomerular, interstitial, infective or pigment patterns.
- Interpretation and limitations
- Blood plus substantial protein supports glomerular disease; leukocytes can accompany infection or interstitial nephritis; haem-positive urine with few red cells suggests myoglobin. Quantify unexpected protein and interpret infection markers with symptoms and culture.
- 04
Full blood count, CRP, venous blood gas and relevant cultures
Differential diagnosis
Chronic kidney disease
A stable high creatinine, small kidneys, longstanding albuminuria or chronic anaemia and mineral-bone changes suggest CKD; historical results distinguish stable CKD from AKI and reveal acute-on-chronic injury.
Drug-related creatinine rise
Trimethoprim, cobicistat and other transporter inhibitors can raise creatinine by reducing tubular secretion without a matching fall in GFR; timing, clinical stability and an alternative filtration marker may expose this mimic.
Creatinine production or dilution
Muscle injury, creatine intake or assay interference can increase creatinine, whereas low muscle mass and fluid accumulation can conceal injury; interpret the biochemical change with urine output and trajectory.
Apparent oliguria
Incomplete collection, catheter kinking, drainage-bag position or unrecorded voids can mimic oliguria; bladder retention is genuine post-renal risk and must not be dismissed as a charting problem.
Acute kidney disease
Subacute kidney dysfunction persisting for 7 to 90 days may represent acute kidney disease rather than resolved AKI or established CKD; the timeline and repeat values determine the appropriate temporal label.
Management
01First hourStabilise and establish severityFirst stepA laboratory alert, new oliguria or clinical suspicion of acute renal dysfunction.+
- 11. Perform ABCDE, obtain observations, assess perfusion and congestion, verify urine output and check the catheter or bladder when relevant.
- 22. Send urgent creatinine, electrolytes and venous gas, obtain an ECG if potassium may be raised, and begin treatment of any immediate physiological threat.
- 33. Retrieve baseline results, apply both creatinine and urine-output criteria, record the highest stage and document the direction and speed of change.
- 44. Review medicines and exposures, treat sepsis or shock promptly, and call renal, critical care or urology early when complications or diagnostic red flags are present.
02Cause searchDifferentiate perfusion, parenchymal injury and obstructionOnce immediate threats are controlled or when the mechanism is not already secure.+
Complications
Hyperkalaemia and acidosis
Reduced potassium and acid excretion can cause malignant arrhythmia, muscle weakness and severe acidaemia; trajectory and physiological effects matter more than the creatinine stage alone.
Fluid overload
Salt and water retention, capillary leak and excessive resuscitation can produce pulmonary oedema, impaired oxygenation and difficult drug or nutritional delivery.
Uraemic organ dysfunction
Severe or sustained AKI can cause encephalopathy, pericarditis, bleeding tendency, nausea and nutritional decline, prompting urgent specialist assessment for kidney replacement therapy.
Medicine accumulation
Reduced clearance can expose patients to opioid, antimicrobial, anticoagulant and other toxicity, while indiscriminate medicine cessation can remove essential cardiovascular or endocrine treatment.
Incomplete recovery
AKI can leave persistent kidney dysfunction, increase later CKD and recurrent-AKI risk, prolong admission and raise short- and long-term mortality.
Monitoring and follow-up
- Record creatinine, potassium and bicarbonate at a frequency matched to trajectory and treatment; unstable severe AKI may require several checks within a day rather than a routine next-morning panel.
- Measure urine output hourly when clinically necessary, validate catheter function and calculate cumulative balance rather than inferring renal recovery from one void.
- Repeat weight, oxygen requirement, lung examination, perfusion and oedema assessment because iatrogenic fluid overload can coexist with poor effective circulation.
- Track medicine holds, renal dose adjustments and serum drug levels where applicable, with a named decision point for restarting prognostic therapies.
- Document AKI stage, presumed cause, peak creatinine and recovery in the discharge communication, together with the date and owner of follow-up blood tests.
Special situations
The baseline can change the diagnosis
A result inside the laboratory reference range may still be a large relative rise for a frail person with low muscle mass. Conversely, a high but stable value may be CKD rather than new AKI. Historical data are therefore part of the diagnostic test.
Fluid balance alters creatinine
Large positive balance expands the distribution volume and can blunt the measured rise, so apparent biochemical stability after resuscitation should be compared with urine output, illness severity and cumulative fluid.
Stage is not the mechanism
Stage describes severity and prognosis. It does not distinguish dehydration from tubular injury, glomerulonephritis or obstruction, and the causal assessment must continue after the alert is acknowledged.
Renal-dose review is dynamic
Estimated GFR equations assume relatively stable creatinine and are unreliable during rapid change. Dose decisions in AKI need the trajectory, clinical toxicity risk, drug levels where available and pharmacy or specialist advice.
Recovery is not discharge from risk
Even when creatinine returns near baseline, an AKI episode predicts later CKD and recurrent AKI. Clear follow-up, medicine reconciliation and prevention advice are components of treatment, not administrative extras.
Common pitfalls
- 01
Calling AKI only when creatinine exceeds the laboratory reference range misses substantial relative rises and delays staging in people with low baseline creatinine.
- 02
Using the current eGFR as though filtration were in steady state can falsely reassure or lead to unsafe drug dosing during a rapidly changing creatinine.
- 03
Giving repeated fluid because urine output remains low, without reassessing lungs and venous congestion, can convert renal injury into life-threatening pulmonary oedema.
- 04
Assuming a patent-looking catheter excludes obstruction overlooks kinking, debris, retention above the balloon or upper-tract disease.
- 05
Stopping ACE inhibitors, diuretics or diabetes medicines without documenting why, when to review and who will restart them creates avoidable long-term cardiovascular harm.